Niagen Bioscience (NAGE) Current Assets (2011 - 2026)

Niagen Bioscience (NAGE) has 14 years of Current Assets data on file, last reported at $105.1 million in Q1 2026.

• Current Assets for Q1 2026 came in at $105.1 million, up 37.92% year-over-year; the trailing twelve-month figure through Mar 2026 was $105.1 million (up 37.92% YoY), and the FY2025 annual result was $96.8 million, up 51.02% from the prior year.
• Current Assets climbed to $105.1 million in Q1 2026 per NAGE's latest filing, from $96.8 million in the prior quarter.
• Over five years, Current Assets peaked at $105.1 million in Q1 2026 and troughed at $37.9 million in Q3 2022.
• A 5-year average of $60.6 million and a median of $49.3 million in 2024 frame the typical range for Current Assets.
• The sharpest annual moves came in 2022 and 2025: Current Assets slumped 33.53% in 2022, then surged 79.57% in 2025.
• A 5-year view of Current Assets shows it stood at $46.6 million in 2022, then gained by 6.37% to $49.5 million in 2023, then rose by 29.41% to $64.1 million in 2024, then soared by 51.02% to $96.8 million in 2025, then rose by 8.59% to $105.1 million in 2026.
• Business Quant data shows NAGE's Current Assets at $105.1 million in Q1 2026, $96.8 million in Q4 2025, and $93.6 million in Q3 2025.